- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-194/21: Judgment of the General Court of 21 December 2021 — Fidia farmaceutici v EUIPO — Stelis Biopharma (HYALOSTEL ONE) (EU trade mark — Opposition proceedings — International figurative registration designating the European Union — Figurative mark HYALOSTEL ONE — Earlier EU word mark HYALISTIL and earlier figurative mark HyalOne — Earlier international word mark HYALO — Relative ground for refusal — Article 8(1)(b) of Regulation (EU) 2017/1001 — Obligation to state reasons)
ECLI:EU:UNKNOWN:62021TA0194
62021TA0194
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
28.2.2022
Official Journal of the European Union
C 95/33
(Case T-194/21) (*)
(EU trade mark - Opposition proceedings - International figurative registration designating the European Union - Figurative mark HYALOSTEL ONE - Earlier EU word mark HYALISTIL and earlier figurative mark HyalOne - Earlier international word mark HYALO - Relative ground for refusal - Article 8(1)(b) of Regulation (EU) 2017/1001 - Obligation to state reasons)
(2022/C 95/45)
Language of the case: English
Parties
Applicant: Fidia farmaceutici SpA (Abano Terme, Italy) (represented by: R. Kunz-Hallstein and H.P. Kunz-Hallstein, lawyers)
Defendant: European Union Intellectual Property Office (represented by: E. Sliwinska and V. Ruzek, acting as Agents)
Other party to the proceedings before the Board of Appeal of EUIPO: Stelis Biopharma Ltd (Karnataka, India)
Re:
Action brought against the decision of the Fifth Board of Appeal of EUIPO of 27 January 2021 (Case R 831/2020-5), relating to opposition proceedings between Fidia Farmaceutici and Stelis Biopharma.
Operative part of the judgment
The Court:
1.Annuls the decision of the Fifth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 27 January 2021 (Case R 831/2020-5);
2.Orders EUIPO to bear its own costs and to pay those incurred by Fidia farmaceutici SpA in connection with the present proceedings.
*
(*) Language of the case: English.
(1) OJ C 217, 7.6.2021.